192 related articles for article (PubMed ID: 30160393)
1. The burden of cardiovascular disease in patients with diabetes.
Hudspeth B
Am J Manag Care; 2018 Aug; 24(13 Suppl):S268-S272. PubMed ID: 30160393
[TBL] [Abstract][Full Text] [Related]
2. Primary Prevention of Cardiovascular Disease in Diabetes Mellitus.
Newman JD; Schwartzbard AZ; Weintraub HS; Goldberg IJ; Berger JS
J Am Coll Cardiol; 2017 Aug; 70(7):883-893. PubMed ID: 28797359
[TBL] [Abstract][Full Text] [Related]
3. [Cardiovascular disease prevention in adults with type 2 diabetes mellitus according to the recent statement from the American Heart Association/American Diabetes Association].
Avogaro A
G Ital Cardiol (Rome); 2016 Mar; 17(3 Suppl 2):5S-11. PubMed ID: 27030118
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular disease in diabetes.
Zhang PY
Eur Rev Med Pharmacol Sci; 2014; 18(15):2205-14. PubMed ID: 25070828
[TBL] [Abstract][Full Text] [Related]
5. Optimal Dietary Strategies for Prevention of Atherosclerotic Cardiovascular Disease in Diabetes: Evidence and Recommendations.
Liday C; Kirkpatrick C
Curr Cardiol Rep; 2019 Oct; 21(11):132. PubMed ID: 31624930
[TBL] [Abstract][Full Text] [Related]
6. Traditional Cardiovascular Risk Factors in Adolescents with Type 1 Diabetes Mellitus.
Donaghue K; Jeanne Wong SL
Curr Diabetes Rev; 2017; 13(6):533-543. PubMed ID: 28120713
[TBL] [Abstract][Full Text] [Related]
7. Economic implications with newer agents to reduce cardiovascular risk in diabetes.
McAdam-Marx C
Am J Manag Care; 2018 Aug; 24(13 Suppl):S279-S285. PubMed ID: 30160395
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular disease risk among Chinese antiretroviral-naïve adults with advanced HIV disease.
Guo F; Hsieh E; Lv W; Han Y; Xie J; Li Y; Song X; Li T
BMC Infect Dis; 2017 Apr; 17(1):287. PubMed ID: 28427339
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of cardiovascular disease and risk factors among type 2 diabetes patients followed in a hospital setting in Portugal: The PICT2RE observational study.
Cardoso H; Tavares Bello C; Andrade L; Sobral do Rosário F; Louro J; Nogueira C; Rodrigues E; Vieira NB; Carqueja T;
Rev Port Cardiol; 2023 Apr; 42(4):319-330. PubMed ID: 36634764
[TBL] [Abstract][Full Text] [Related]
10. Ameliorating Cardiovascular Risk in Patients with Type 2 Diabetes.
Motairek I; Al-Kindi S
Endocrinol Metab Clin North Am; 2023 Mar; 52(1):135-147. PubMed ID: 36754490
[TBL] [Abstract][Full Text] [Related]
11. Diabetes mellitus: a cardiovascular disease.
Candido R; Srivastava P; Cooper ME; Burrell LM
Curr Opin Investig Drugs; 2003 Sep; 4(9):1088-94. PubMed ID: 14582453
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular risk factor progression in adolescents and young adults with youth-onset type 2 diabetes.
; Shah RD; Braffett BH; Tryggestad JB; Hughan KS; Dhaliwal R; Nadeau KJ; Levitt Katz LE; Gidding SS
J Diabetes Complications; 2022 Mar; 36(3):108123. PubMed ID: 35123868
[TBL] [Abstract][Full Text] [Related]
13. Is the risk and nature of CVD the same in type 1 and type 2 diabetes?
Duca L; Sippl R; Snell-Bergeon JK
Curr Diab Rep; 2013 Jun; 13(3):350-61. PubMed ID: 23519720
[TBL] [Abstract][Full Text] [Related]
14. Measures of atherosclerotic burden are associated with clinically manifest cardiovascular disease in type 2 diabetes: a European cross-sectional study.
Shore AC; Colhoun HM; Natali A; Palombo C; Östling G; Aizawa K; Kennbäck C; Casanova F; Persson M; Gooding K; Gates PE; Khan F; Looker HC; Adams F; Belch J; Pinnoli S; Venturi E; Morizzo C; Goncalves I; Ladenvall C; Nilsson J;
J Intern Med; 2015 Sep; 278(3):291-302. PubMed ID: 25752315
[TBL] [Abstract][Full Text] [Related]
15. Cost-utility of empagliflozin in patients with type 2 diabetes at high cardiovascular risk.
Nguyen E; Coleman CI; Nair S; Weeda ER
J Diabetes Complications; 2018 Feb; 32(2):210-215. PubMed ID: 29157870
[TBL] [Abstract][Full Text] [Related]
16. Impact of cardiovascular complications among patients with Type 2 diabetes mellitus: a systematic review.
Vaidya V; Gangan N; Sheehan J
Expert Rev Pharmacoecon Outcomes Res; 2015 Jun; 15(3):487-97. PubMed ID: 25824591
[TBL] [Abstract][Full Text] [Related]
17. Preventing cardiovascular disease in diabetes and glucose intolerance: evidence and implications for care.
Rennert NJ; Charney P
Prim Care; 2003 Sep; 30(3):569-92. PubMed ID: 14692202
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular diseases and risk factors knowledge and awareness in people with type 2 diabetes mellitus: a global evaluation.
Saeedi P; Karuranga S; Hammond L; Kaundal A; Malanda B; Prystupiuk M; Matos P
Diabetes Res Clin Pract; 2020 Jul; 165():108194. PubMed ID: 32389743
[TBL] [Abstract][Full Text] [Related]
19. Comparison of 3 risk estimators to guide initiation of statin therapy for primary prevention of cardiovascular disease.
Ofori S; Dodiyi-Manuel S; Akpa MR
J Clin Lipidol; 2017; 11(6):1441-1447. PubMed ID: 29050979
[TBL] [Abstract][Full Text] [Related]
20. Humanistic and economic burden of cardiovascular disease related comorbidities and hypoglycaemia among patients with type 2 diabetes in Japan.
Terauchi Y; Ozaki A; Zhao X; Teoh C; Jaffe D; Tajima Y; Shuto Y
Diabetes Res Clin Pract; 2019 Mar; 149():115-125. PubMed ID: 30685348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
